Volume 10, Issue 4 (8-2012)                   IJRM 2012, 10(4): 307-314 | Back to browse issues page

XML Persian Abstract Print

Download citation:
BibTeX | RIS | EndNote | Medlars | ProCite | Reference Manager | RefWorks
Send citation to:
Chanukvadze D, Kristesashvili J, Kvashilava N. Correlation of biochemical markers and clinical signs of hyperandrogenism in women with polycystic ovary syndrome (PCOS) and women with non-classic congenital adrenal hyperplasia (NCAH). IJRM 2012; 10 (4) :307-314
URL: http://ijrm.ir/article-1-302-en.html
Correlation of biochemical markers and clinical signs of hyperandrogenism in women with polycystic ovary syndrome (PCOS) and women with non-classic congenital adrenal hyperplasia (NCAH)
Diana Chanukvadze * 1, Jenara Kristesashvili2 , Nana Kvashilava3
1- Department of Gynecology, Obstetrics and Reproductology, Medical Faculty, I. Javakhishvili Tbilisi State University, Tbilisi, Georgia , Diana.chanukvadze@ gmail. com
2- Department of Gynecology, Obstetrics and Reproductology, Medical Faculty, I. Javakhishvili Tbilisi State University, Tbilisi, Georgia
3- Hormonal Laboratory of Zhordania Institute of Human Reproduction, Tbilisi, Georgia
Abstract:   (4211 Views)
Background: Polycystic ovary syndrome (PCOS) is the most common cause of hyperandrogenism in women. Non-classic congenital adrenal hyperplasia (NCAH) is very close to PCOS. The diagnosis of hyperandrogenism is not based on the finding of decreased or increased levels of a single hormone. Objective: In our paper, we are going to test correlation between clinical signs and biochemical markers of hyperandrogenism.
Materials and Methods: In this prospective study, we calculated free testosterone (cFT), bioavailable testosterone (cBT), free androgen index (FAI), free estrogen index (FEI), total testosterone (TT), sex-hormone binding globulin (SHBG), estradiol (E2), dehydroepiandrosterone-sulfat (DHEA-S), 17α -hydroxyprogesterone (17α -OHP), prolactin (P), C-peptid and homeostasis model assessment for insulin resistance (Homa-IR) were measured in two groups of young untreated women with PCOS and NCAH.
Results: In our research, we did not find any significant differences between PCOS and NCAH groups by age, hormonal and calculated parameters of androgens. Waist to hip ratio (WHP) and body mass index (BMI) values were higher in the group of patients with PCOS than NCAH group. But in all patients we found positive correlation between hirsutism score and FAI, cFT, cBT, as well as we found negative correlation between hirsutism score and SHBG. We also tested hormonal and calculated parameters of androgens between PCOS patients by upper body and lower body obesity, but we did not find any significant differences. There was not any difference by the hirsutism score in these groups either.
Conclusion: In our research we found that the calculated values of cFT, cBT and FAI are helpful for determinate hirsutism score in all hirsute patients, despite of ovarian or adrenal hyperandrogenemia.
Keywords: Hirsutism, Hyperandrogenemia, Free androgen index (FAI), Polycystic ovary syndrome (PCOS), Non-classic congenital adrenal hyperplasia (NCAH)
Full-Text [PDF 387 kb]   (913 Downloads) |   |   Full-Text (HTML)  (852 Views)  
Type of Study: Original Article |
References
1. Asuncion M, Calvo RM, San Millan JL, Sancho J, Avila S, Escobar-Morreale HF. A prospective study of the prevalence of the polycystic ovary syndrome in unselected Caucasian women from Spain. J Clin Endocrinol Metab 2000; 85: 2434-2438. [DOI:10.1210/jc.85.7.2434]
2. Diamanti-Kandarakis E, Kouli CR, Bergiele AT, Filandra FA, Tsianateli TC, Spina GG, et al. A survey of the polycystic ovary syndrome in the Greek island of Lesbos: hormonal and metabolic profile. J Clin Endocrinol Metab 1999; 84: 4006-4011. [DOI:10.1210/jcem.84.11.6148]
3. Knochenhauer ES, Key TJ, Kahsar-Miller M, Waggoner W, Boots LR, Azziz R. Prevalence of the polycystic ovary syndrome in unselected black and white women of the southeastern United States: a prospective study. J Clin Endocrinol Metab 1998; 83: 3078-3082. [DOI:10.1210/jc.83.9.3078]
4. Kraw M. Diagnosing Hyperandrogenism in Women. Endocrinol Rnds 2006; 6: 1-6.
5. Moran C, Azziz R, Carmina E, Dewailly D, Fruzzetti F, Ibanez L, et al. 21-Hydroxylasedeficient nonclassic adrenal hyperplasia is a progressive disorder: a multicenter study. Am J Obstet Gynecol 2000; 183: 1468-1474. [DOI:10.1067/mob.2000.108020]
6. Moran C. Nonclassic adrenal hyperplasia. Fertil Steril 2006; 86 (Suppl.): S3. [DOI:10.1016/j.fertnstert.2006.03.004]
7. Cibula D, Hill M, Starka L. The best correlation of the new index of hyperandrogenism with the grade of increased body hair. Eur J Endocrinol 2000; 143; 405-408. [DOI:10.1530/eje.0.1430405]
8. Rotterdam ESHRE/ ASRM-sponsored PCOS consensus workshop group. Revised 2003 consensus on diagnostic criteria and long term health risks related to polycystic ovary syndrome. Fertil Steril 2004; 81: 19-25. [DOI:10.1016/j.fertnstert.2003.10.004]
9. Rotterdam ESHRE/ ASRM-sponsored PCOS Consensus Workshop Group. Revised 2003 consensus on diagnostic criteria and long term health risk related to polycystic ovary syndrome (PCOS). Hum Reprod 2004; 19: 1-7.
10. Ferriman D, Gallwey JD. Clinical assessment of body hair growth in women. J Clin Endocrinol Metab 1961; 21: 1440-1447. [DOI:10.1210/jcem-21-11-1440]
11. Lorenzo EM. Familial study of hirsutism. J Clin Endocrinol Metab 1970; 31: 556-564. [DOI:10.1210/jcem-31-5-556]
12. Vermeulen A, Verdonck L, Kaufmann JM. A critical evaluation of simple methods for the estimation of free testosterone in serum. J Clin Endocrinol Metab 1999; 84: 3666-3672. [DOI:10.1210/jcem.84.10.6079]
13. Mathur RS, Moody LO, Landgrebbe S, Williamson HO. Plasma androgens and sex hormone binding globulin in the evaluation of hirsute patients. Fertil Steril 1981; 35: 29-37. [DOI:10.1016/S0015-0282(16)45254-4]
14. Azziz R, Carmina E, Dewailly D, Diamanti-Kandarakis E, Escobar-Morreale HF, Futterweit W, et al. Androgen Excess Society. Positions statement: criteria for defining polycystic ovary syndrome as a predominantly hyperandrogenic syndrome: an Androgen Excess Society guideline. J Clin Endocrinol Metab 2006; 91; 4237-4245. [DOI:10.1210/jc.2006-0178]
15. Azziz R, Carmina E, Sawaya ME. Idiopathic Hirsutism. Endocr Rev 2000; 21: 347-362. [DOI:10.1210/er.21.4.347]
16. Von Shoultz B, Calstrom K. On the regulation of sex-hormone binding globulin. A challenge of old dogma and outlines of an alternative mechanism. J Steroid Biochem 1982; 32; 327-334. [DOI:10.1016/0022-4731(89)90272-0]
17. Pasquali R, Casimirri F, Plate ÁL, Capelli M. Characterization of obese women with reduced sex hormone-binding globulin concentrations. Horm Metab Res 1990; 22: 303-306. [DOI:10.1055/s-2007-1004907]
18. Dunaif A. Insulin resistance and the polycystic ovary syndrome: mechanism and implications for pathogenesis. Endocr Rev 1997; 18: 774-800. [DOI:10.1210/er.18.6.774]
19. Ehrmann DA, Barnes RB, Rosenfield RL, Cavaghan MK, Imperial J. Prevalence of impaired glucose tolerance and diabetes in women with polycystic ovary syndrome. Diabetes Care 1999; 22: 141-146. [DOI:10.2337/diacare.22.1.141]
20. Hauner H, Ditschuneit HH, Pal SB, Moncayo R, Keiffer EF. Fat distribution, endocrine and metabolic profile in obese women with and without hirsutism. Metabolism 1988; 37: 281-286. [DOI:10.1016/0026-0495(88)90109-6]
21. Golden SH, Ding J, Szklo M, Schmidt MI, Duncan BB, Dobs A. Glucose and insulin components of the metabolic syndrome are associated with hyperandrogenism in postmenopausal women: the atherosclerosis risk in communities study. Am J Epidemiol 2004; 160: 540-548. [DOI:10.1093/aje/kwh250]
22. Huppert J, Chiodi M, Hillard PJ. Clinical and metabolic findings in adolescent females with hyperandrogenism. J Pediatr Adolesc Gynecol 2004; 17: 103-108. [DOI:10.1016/j.jpag.2004.01.005]
Send email to the article author

Rights and permissions
Creative Commons License This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.

Designed & Developed by : Yektaweb